Emerging Biotech
Achieve Launch Excellence
with Confidence and Speed
Getting your innovation to patients, faster.
40%
faster treatment adoption with pre-launch HCP scientific engagement
39%
of first-time launchers achieve their sales forecast
44%
of HCPs are satisfied with pharma engagement at launch
4x
digitally-savvy HCPs 4× as likely to start patients on a new treatment
eBook
Pre-commercial Guide to Launch Excellence
Identify the right mix of go-to-market plans and operational capabilities in this pre-commercial roadmap for biopharmas.
“The market’s changing on a daily basis so being able to capture and share real-time data about our top KOLs has been really impactful.”
Chris Deluzio
Executive Vice President, Enterprise Operations, NewAmsterdam Pharma
“Technology is a key enabler for every step of a product launch. Building comprehensive IT capabilities within the complex and regulated pharma industry while meeting strict deadlines is possible with a readily available platform like Veeva that covers the full technology stack, from clinical to commercial.”
Joseph Bejjani
CIO, Idorsia
“With Veeva as our trusted partner, we accelerated launch readiness and equipped new sales, medical, and marketing teams with the digital tools they need.”
Christopher Mutz
Chief Commercial Officer & Head of Rare Disease, ANI Pharmaceuticals
“As you prepare for launch, medical insights become especially valuable — helping to shape medical strategy, refine scientific communications, and guide overall impact in the field.”
Kristina Kipp
Regional Medical Director, BridgeBio
Our Customers
Succeed in your launch strategy, from planning to efficient commercial execution
Launch solutions
for emerging biotech
Learn why hundreds of pre-commerial companies rely on Veeva to plan and execute their launch.
